In ED patients that do not respond to PDE5i monotherapy ~30-40% of ED patients do not respond to PDE5i treatment Data from this Phase 2 clinical study is expected by end of calendar year 2024 Published clinical data and mechanisms of action support clinical study of bremelanotide in…

COLD SPRING HARBOR, N.Y., June 20, 2024 /PRNewswire/ — It reads. It talks. It collates mountains of data and recommends business decisions. Today’s artificial intelligence might seem more human than ever. However, AI still has several critical shortcomings. Cold Spring Harbor Laboratory…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.